Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

173
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
173
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

250
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
250
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

397
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
397
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

228
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
228
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

352
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
352
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

193
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
193

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trend and clinical outcomes of transcatheter aortic valve replacement in connective tissue disease from the national inpatient sample database (2016-2022).

Journal of cardiothoracic surgery·2026
Same author

A State-of-the-Art Review Exploring the Cardiovascular Outcomes of Renin-Angiotensin Inhibitors in Acute Kidney Injury.

Cardiorenal medicine·2026
Same author

Development of Urinalysis Screening Criteria for Rhabdomyolysis in Acute Kidney Injury.

Kidney360·2026
Same author

Sex-related disparities in incidence and in-hospital outcomes of Atrial fibrillation complicated by non-ST-elevation myocardial infarction from the national in-sample database (2016-2022).

International journal of cardiology. Heart & vasculature·2026
Same author

Sodium Glucose Co-Transporter 2 Inhibitors in Patients With Heart Failure and Transcatheter Aortic Valve Replacement.

JACC. Advances·2026
Same author

Two-Decade Trends in Colorectal Cancer and Cardiovascular Disease-Related Mortality in the US Adult Population, 1999 to 2019.

Journal of the American Heart Association·2026

Related Experiment Video

Updated: Aug 26, 2025

Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa
08:17

Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa

Published on: September 27, 2018

8.6K

Electrical neuromodulation therapy for inflammatory bowel disease.

Farah Yasmin1, Abdul Moiz Sahito1, Syeda Lamiya Mir1

  • 1Department of Medicine, Dow University of Health Sciences, Karachi 74200, Pakistan.

World Journal of Gastrointestinal Pathophysiology
|October 3, 2022
PubMed
Summary

Electrical neuromodulation offers a promising alternative for inflammatory bowel disease (IBD) treatment, with studies showing encouraging results. Further research, including randomized controlled trials, is needed to confirm its efficacy and understand its mechanisms.

Keywords:
Crohn’s diseaseElectrical neuromodulationInflammatory bowel diseaseNeuromodulationSacral nerve stimulationTibial nerve stimulationUlcerative colitisVagus nerve stimulation

More Related Videos

Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity
11:34

Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity

Published on: January 10, 2013

23.2K
Electrode Positioning and Montage in Transcranial Direct Current Stimulation
12:00

Electrode Positioning and Montage in Transcranial Direct Current Stimulation

Published on: May 23, 2011

263.1K

Related Experiment Videos

Last Updated: Aug 26, 2025

Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa
08:17

Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa

Published on: September 27, 2018

8.6K
Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity
11:34

Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity

Published on: January 10, 2013

23.2K
Electrode Positioning and Montage in Transcranial Direct Current Stimulation
12:00

Electrode Positioning and Montage in Transcranial Direct Current Stimulation

Published on: May 23, 2011

263.1K

Area of Science:

  • Gastroenterology
  • Neuromodulation
  • Medical Devices

Background:

  • Inflammatory bowel disease (IBD) significantly impacts patient quality of life and finances.
  • Current IBD treatments have limitations, with many patients unresponsive or experiencing severe side effects.
  • Electrical neuromodulation presents a potential alternative therapeutic strategy for IBD.

Purpose of the Study:

  • To review the current data on electrical neuromodulation therapies for inflammatory bowel disease (IBD).
  • To discuss the various techniques studied, including vagus nerve stimulation, sacral nerve stimulation, and tibial nerve stimulation.
  • To highlight the need for further investigation into the mechanisms and efficacy of these therapies.

Main Methods:

  • Review of existing animal and clinical studies on electrical neuromodulation for IBD.
  • Analysis of different neuromodulation techniques applied to gastrointestinal disorders.
  • Discussion of the current understanding of bioelectric neuromodulation technology.

Main Results:

  • Encouraging results have been observed in preliminary animal and clinical experiments.
  • Sacral nerve stimulation (SNS) is the only established neuromodulation protocol for GI disease (fecal incontinence).
  • Several techniques like vagus nerve stimulation (VNS), SNS, and tibial nerve stimulation (TNS) show potential for IBD.

Conclusions:

  • Electrical neuromodulation is a promising modality for IBD treatment.
  • The precise mechanisms of action require further elucidation.
  • Randomized controlled trials are essential to validate the efficacy of intrinsic processes and establish therapeutic protocols.